Previous work has shown that inhibition of AHR in liver lead to steatosis, potentially via AHR inhibition of peroxisomal beta oxidation of fatty acids50 or decreased expression of a transporter like OAT1, which contributes to lipid metabolism31. The gene discussed is SLC22A6; the disease is steatosis.